Some links on this page are affiliate links: if you buy through them we may earn a commission, at no extra cost to you.
Theranos’s Edison was a proprietary blood-testing analyzer promoted as a way to run a broad range of tests quickly from a tiny finger-stick sample. The central problem was not simply that the technology was new or miniaturized: court records describe a gap between the promised breadth and performance and what the systems could reliably do. They describe a limited test menu, accuracy and reliability problems, quality-control failures, and an inability to match conventional analyzers for high-volume testing.
The evidence needs careful framing. Some claims about the technology appear in an indictment, which sets out allegations; later appellate materials summarize trial testimony about quality-control failures, while the Justice Department separately reported a jury verdict on investor-fraud charges. Those are different kinds of records, not interchangeable proof of every technical claim.
What was the Theranos Edison machine supposed to do?
Theranos marketed a proprietary analyzer that legal records refer to as the Theranos Sample Processing Unit (TSPU), Edison, or miniLab. The investor-facing proposition was strikingly simple: collect a small amount of blood with a finger stick, then use the company’s system to run a broad menu of tests more quickly and accurately than conventional laboratory methods. The indictment excerpt describes claims along those lines and alleges that the devices’ actual capabilities fell short.
That promise combined several different technical and operational claims. A small collection sample is one claim; the ability to run many kinds of assays from it is another. A test result also needs to be accurate and repeatable, and a laboratory must be able to process samples at a useful rate while checking that its instruments and procedures remain dependable. Success on one of those dimensions does not establish success on the others.
Popular on Amazon
- 【90 Degree Full Function USB C Adapter】Supports the latest USB4 standard for up to 40Gbps of bandwidth, 8K video support, and up to 240W Fast charging; Support USB PD 3.1 Extended Power Range (EPR) including 140W, 180W and 240W. Your productivity is easily doubled. *Warm Tip: For the best fit, please make sure the USB-C port is fully exposed; thick or bulky cases may affect compatibility.
- 【Reliable Quality】Made from high-quality, scratch-resistant aluminum alloy, delicate metal frame. get excellent wear resistance and heat dissipation. Non-Slip Design for easier insertion and removal.
- 【Small and portable】Ultra thin size, ultra compact design, a petite physique that matches the minimalist design of your modern laptops. Coming with a slim figure that won't block the port next to the one it's plugged into.
- 【Compatibility】Widely work with most usb c, thunderbolt 4/3 devices. Compatibilit for ROG Ally, Steam Deck, Switch, MacBook Pro, Quest 3 VR headset, Surface Book 2, iPhone 18/17/16/15, Samsung Galaxy S23/S22/S21, Note 20/10, Google Pixel, ChromeBook, etc.
- 【Excellence Customer Support】If you experience any issues or cable failure, simply reach out to our dedicated customer service team. We provide a prompt response within 18 hours, providing you with the necessary technical support to resolve any concerns.
The records in the available evidence use the names TSPU, Edison, and miniLab in describing Theranos’s proprietary analyzer. They do not provide a full engineering schematic or a test-by-test table that would let a reader reconstruct exactly how each version worked. It is therefore more accurate to explain the promise and documented limitations than to invent a detailed account of its internal mechanics.
How did the advertised idea differ from a dependable lab test?
A finger-stick collection method and a dependable laboratory result are not the same thing. The sample must be suitable for the particular assay, the instrument and assay must produce reliable measurements, and quality controls must give the laboratory confidence that the process is working. A broad menu raises the further question of whether those conditions hold across many different tests, rather than just a selected few.
Those are general requirements for understanding the claim, not a description of a specific Edison mechanism. The cited legal records do not supply enough engineering detail to identify a single physical or chemical cause for every reported problem. They do, however, describe broad limitations in accuracy, reliability, available tests, and throughput. A responsible explanation should stop at what those sources establish instead of guessing about sample dilution, sensor design, or other possible technical causes.
Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minuteWindows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallThe same distinction applies to speed. A machine may produce an individual result quickly yet still be a poor fit for a busy laboratory if it can run only a limited set of tests, requires workflow steps that slow processing, or cannot handle many samples at once. The indictment alleged both that the devices were slower than some competing devices and that they could not compete with larger conventional analyzers for high-throughput, simultaneous testing. It does not provide a complete model-by-model speed comparison.
Why did Theranos blood tests fail?
The legal record describes several linked shortcomings, rather than one publicly established failure rate or one definitive engineering defect. The indictment alleged that the analyzers had accuracy and reliability problems, supported only a limited number of tests, and were not suited to the high-throughput role implied by Theranos’s claims. The appellate record also summarizes trial testimony that Edison devices repeatedly failed quality-control checks and could not provide accurate results.
Also popular on Amazon
- 5-in-1 Connectivity: Equipped with a 4K HDMI port, a 5 Gbps USB-C data port, two 5 Gbps USB-A ports, and a USB C 100W PD-IN port. Note: The USB C 100W PD-IN port supports only charging and does not support data transfer devices such as headphones or speakers.
- Powerful Pass-Through Charging: Supports up to 85W pass-through charging so you can power up your laptop while you use the hub. Note: Pass-through charging requires a charger (not included). Note: To achieve full power for iPad, we recommend using a 45W wall charger.
- Transfer Files in Seconds: Move files to and from your laptop at speeds of up to 5 Gbps via the USB-C and USB-A data ports. Note: The USB C 5Gbps Data port does not support video output.
- HD Display: Connect to the HDMI port to stream or mirror content to an external monitor in resolutions of up to 4K@30Hz. Note: The USB-C ports do not support video output.
- What You Get: Anker 332 USB-C Hub (5-in-1), welcome guide, our worry-free 18-month warranty, and friendly customer service.
These limitations matter together. A restricted test menu would undercut a claim of broad testing. Accuracy and reliability problems would undermine confidence in results, even for tests the system could perform. A failure to process many samples at once would make the system less capable of serving as a replacement for conventional laboratory equipment at scale. The documented case is therefore about a mismatch between what was promoted and what the system could support—not a source-backed finding that every Edison result was wrong.
Quality control is especially important because it is how a laboratory checks that its testing process is performing acceptably. A failed check is a warning that a system should not be treated as dependable without addressing the problem and establishing that it is working. The Ninth Circuit appellate record summarizes trial testimony about repeated Edison quality-control failures. It also notes that the Centers for Medicare & Medicaid Services (CMS) conducted an unannounced inspection of the Theranos laboratory in late 2015.
Quick wins for a faster PC:
Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Clear out junk files and repair common Windows errorsFree Scan →The cited appellate material does not provide a comprehensive, assay-by-assay failure-rate breakdown. It would be misleading to turn the reported quality-control failures into an unsupported percentage, or to imply that one figure captures the performance of every test, device, or period of operation. The record supports a serious reliability problem; it does not supply a universal numeric score for Edison.
What was wrong with the Edison blood-testing technology?
The core issue was that a bold product proposition was treated as though it established performance across the whole testing system. It did not. The legal records describe a limited test menu, accuracy and reliability concerns, quality-control problems, and shortcomings in speed and throughput. Each limitation challenges a different part of the promise.
| Claim or requirement | What the legal record says | What readers should take from it |
|---|---|---|
| Small finger-stick sample | Theranos promoted broad testing using small finger-stick samples. | Sample size and collection method alone do not establish dependable results across a broad menu. |
| Broad range of tests | The indictment alleged that the proprietary analyzer performed only a limited number of tests. | The advertised breadth was not supported by the capabilities described in that charging document. |
| Accuracy and reliability | The indictment described problems; the appellate record summarizes trial testimony about repeated QC failures and inability to provide accurate results. | Reliability concerns were central, but the sources here do not establish one failure rate for every assay. |
| Speed and laboratory-scale operation | The indictment alleged that the devices were slower than some competing devices and could not match larger analyzers for high-throughput, simultaneous testing. | Producing a result is not the same as replacing conventional equipment at operational scale. |
This comparison has limits. The cited documents do not offer a controlled side-by-side dataset for named conventional analyzer models, nor a complete assay-level account of Edison’s performance. They support the broad contrast above, not a precise ranking of individual machines or a claim that every conventional analyzer was faster or more accurate in every situation.
Also popular on Amazon
- Sleek 7-in-1 USB-C Hub: Features an HDMI port, two USB-A 3.0 ports, and a USB-C data port, each providing 5Gbps transfer speeds. It also includes a USB-C PD input port for charging up to 100W and dual SD and TF card slots, all in a compact design.
- Flawless 4K@60Hz Video with HDMI: Delivers exceptional clarity and smoothness with its 4K@60Hz HDMI port, making it ideal for high-definition presentations and entertainment. (Note: Only the HDMI port supports video projection; the USB-C port is for data transfer only.)
- Double Up on Efficiency: The two USB-A 3.0 ports and a USB-C port support a fast 5Gbps data rate, significantly boosting your transfer speeds and improving productivity.
- Fast and Reliable 85W Charging: Offers high-capacity, speedy charging for laptops up to 85W, so you spend less time tethered to an outlet and more time being productive.
- What You Get: Anker USB-C Hub (7-in-1), welcome guide, 18-month warranty, and our friendly customer service.
What did regulators and juries establish—and what did they not?
Theranos’s technology story became part of major legal cases, but legal milestones need to be described precisely. The Securities and Exchange Commission’s March 14, 2018 announcement said that Theranos, Elizabeth Holmes, and former president Ramesh “Sunny” Balwani had been charged over statements about the company’s technology, business, and financial performance. The SEC said the company and executives raised more than $700 million from investors while exaggerating or making false statements. That announcement reports charges and allegations; it is not itself a jury verdict.
Free tools Windows power users keep installed
One-click scans. No signup required.
The SEC named Jina Choi, then director of its San Francisco Regional Office, who said: “The Theranos story is an important lesson for Silicon Valley.” The SEC announcement is relevant to the gap between the company’s public representations and its technology, but its fundraising figure is not a measurement of analyzer performance.
In January 2022, the Department of Justice reported that a jury found Holmes guilty of investor fraud. Its account describes evidence that Holmes represented Theranos would earn more than $100 million and break even in 2014, and that she expected about $1 billion in 2015, while the company generated only modest revenue. These are financial projections and trial evidence as characterized by DOJ, not statistics about how accurately Edison tested blood. The DOJ verdict announcement should be read as an account of a jury outcome, not as a technical evaluation of every assay.
Keeping these records distinct prevents two opposite errors: treating allegations in a charging document as though they were all adjudicated technical findings, or ignoring later trial and appellate records that summarize testimony about quality-control failures. The most defensible account uses each source for what it is: the indictment for allegations about representations and analyzer limits, the appellate record for its summary of trial testimony, and the agency announcements for the legal and financial matters they report.
Could Theranos really run tests from a finger prick?
Theranos did promote testing from small finger-stick samples, but that does not mean the company demonstrated that a tiny sample could support every test it advertised with dependable accuracy. The indictment alleged that the analyzers could perform only a limited number of tests and had accuracy and reliability problems. The available records do not provide a complete menu or a performance table for each assay.
Do these 3 things before closing this tab:
1Scan for outdated or missing drivers - takes under a minute2Clear out junk files and repair common Windows errors3Fix the driver behind crashes, sound loss and screen glitchesAlso popular on Amazon
- Portable and powerful USB-C HUB: BENFEI USB Type-C HUB, with super-soft and knot-free silicone woven design cable, meets most mobile office needs. Compact, lightweight, stylish, and powerful portable USB C Hub equipped with 1 x HDMI port, 1 x 100W charging, and 3 x USB ports. 18-month warranty, 24-hour response, to ensure you feel at ease when using our product.
- Design centered on comfort and reliability: Thanks to BENFEI's end-to-end in-house cable production capability, in-house PCBA and assembly capability, using the industry's most advanced silicone woven design and process, 20cm cable in length, no knots, super-soft, the HUB is easy to use in all scenarios: laptop, tablet, stand etc. Super-soft, 25000+ life cycles, to meet your daily carrying and office needs.
- 100W Charging: Support up to 90W USB C pass-through charging via Type-C port to keep your laptop powered. 10W is reserved for other interface operations. No data and video function on the Type-C port.
- 4K HDMI Display: The HDMI port supports media display at resolutions up to 4K 30Hz, keeping every incredible moment detailed and ultra vivid. Please note that the C port of the Host device needs to support video output.
- Transfer Files in Seconds: Transfer files and from your laptop at speeds up to 10 Gbps with USB A 3.2 port. Extra 2 USB A 2.0 ports are perfectly for your keyboards and mouse.
It is useful to separate collection from analysis. A finger prick describes how blood is collected and the small sample proposition describes the intended input. Neither fact answers whether a particular test can be run reliably from that sample, whether the analyzer can support many test types, or whether the result holds up under quality control. Those are separate questions, and the sources describe problems in those broader capabilities.
Why did the high-throughput issue matter?
Theranos’s proposition implied more than a novel way to collect a sample: it suggested that the proprietary system could serve a broad, practical testing role. Laboratories need to handle multiple patient samples and different test requests, not just demonstrate that an instrument can produce an isolated result. The indictment alleged that Theranos’s device could not compete with larger conventional machines for simultaneous high-volume testing.
That limitation changes how to interpret claims of convenience or speed. A small sample could be useful to a patient, but it would not by itself solve laboratory capacity, reliability, or test-menu constraints. Conversely, a conventional analyzer’s larger size is not proof that it is superior in every respect. The available sources support a specific concern—Edison could not meet the high-throughput role attributed to it—not a universal verdict on every competing instrument.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What is the clearest way to understand the Theranos technology story?
Think of it as a systems problem and a claims problem at once. The marketed vision joined sample collection, a broad menu, speed, accuracy, reliability, and laboratory-scale capacity into one promise. The legal record describes material gaps in several of those dimensions, and the quality-control testimony helps explain why reliable operation mattered as much as the novelty of collecting less blood.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
The evidence does not justify replacing that explanation with a dramatic but unsupported technical mystery. It does not identify a single design flaw that explains every shortcoming, provide a full reconstruction of the analyzer, or quantify the accuracy of every test. What it does establish at a useful level is that the technology described in the records did not perform as the broad, dependable, high-throughput system Theranos promoted.
Also popular on Amazon
- 【Read before You Buy】 Note: This adapter is USB 2.0 version and cannot transmit HDM, VGA, or other video signals. Nevertheless, they are fully capable of charging devices,duplicating files, and can be seamlessly integrated with USB-C earphones, wireless network adapters, and SD card adapters.
- 【Easy to Use and Safe】Thanks to modern manufacturing techniques, we've made these adapters sufficiently compact so that they can remain inserted in your device without noticeable protrusion or inconvenience. This means you don't have to constantly plug and unplug them, reducing the likelihood of wear and misalignment, and making them more convenient to carry around.
- 【Reliable Quality】Engineered for enhanced durability, durable aluminum alloy shell material,get excellent wear resistance and heat dissipation,the male USB C and female USB connectors & the male USB and female USB C connectors are designed to be plugged and unplugged up to 20000 times. Provides data transfer, device charging, memory space expansion, and additional computer peripherals.
- 【Think more for you】Do you need to connect a USB-C-enabled device to an odd device that only has USB-A ports? Then these USB-A male to USB-C female adapters are made for you.Simply insert the adapter into the USB-A port on the device, and you can instantly connect your USB-C device to the device that originally didn't have the correct connection port.
- 【Trusted xiwxi Quality and Service】As a responsible brand seller, you will receive xiwxi's 12-month Quality assurance and lifetime friendly customer service, you're not just buying a product,you're investing in peace of mind with all-round quality and exceptional customer service.
For readers who want a longer narrative history rather than an engineering manual, publisher Penguin Random House lists John Carreyrou’s Bad Blood: Secrets and Lies in a Silicon Valley Startup. It is a narrative account of Theranos, not a substitute for the court and regulatory records cited here. See the publisher’s listing.
Frequently Asked Questions
Was every Theranos test result wrong?
The cited records do not establish that every individual result was wrong. They describe serious accuracy, reliability, and quality-control problems, but do not provide a comprehensive result-by-result or assay-by-assay failure rate.
Did Theranos publish a full technical blueprint for Edison?
The legal records linked here do not provide a complete engineering schematic or a full technical reconstruction. They are useful for understanding the claims, limitations, and evidence summarized in court, rather than for reproducing the machine.
Recommended Free Tools
Where can I read a longer account of Theranos?
John Carreyrou’s Bad Blood is a publisher-listed nonfiction narrative about the company. It offers a longer historical account, while court records and agency announcements are the better sources for the specific legal claims and outcomes discussed here.
Say something about this film